rs11564452

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001904.4(CTNNB1):​c.1082-562A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.395 in 151,752 control chromosomes in the GnomAD database, including 12,242 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.39 ( 12242 hom., cov: 31)

Consequence

CTNNB1
NM_001904.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.247

Publications

12 publications found
Variant links:
Genes affected
CTNNB1 (HGNC:2514): (catenin beta 1) The protein encoded by this gene is part of a complex of proteins that constitute adherens junctions (AJs). AJs are necessary for the creation and maintenance of epithelial cell layers by regulating cell growth and adhesion between cells. The encoded protein also anchors the actin cytoskeleton and may be responsible for transmitting the contact inhibition signal that causes cells to stop dividing once the epithelial sheet is complete. Finally, this protein binds to the product of the APC gene, which is mutated in adenomatous polyposis of the colon. Mutations in this gene are a cause of colorectal cancer (CRC), pilomatrixoma (PTR), medulloblastoma (MDB), and ovarian cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016]
CTNNB1 Gene-Disease associations (from GenCC):
  • exudative vitreoretinopathy
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • severe intellectual disability-progressive spastic diplegia syndrome
    Inheritance: Unknown, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
  • exudative vitreoretinopathy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.451 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001904.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNB1
NM_001904.4
MANE Select
c.1082-562A>T
intron
N/ANP_001895.1P35222
CTNNB1
NM_001098209.2
c.1082-562A>T
intron
N/ANP_001091679.1P35222
CTNNB1
NM_001098210.2
c.1082-562A>T
intron
N/ANP_001091680.1P35222

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CTNNB1
ENST00000349496.11
TSL:1 MANE Select
c.1082-562A>T
intron
N/AENSP00000344456.5P35222
CTNNB1
ENST00000396183.7
TSL:1
c.1082-562A>T
intron
N/AENSP00000379486.3P35222
CTNNB1
ENST00000396185.8
TSL:1
c.1082-562A>T
intron
N/AENSP00000379488.3P35222

Frequencies

GnomAD3 genomes
AF:
0.395
AC:
59877
AN:
151634
Hom.:
12238
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.306
Gnomad AMI
AF:
0.430
Gnomad AMR
AF:
0.364
Gnomad ASJ
AF:
0.380
Gnomad EAS
AF:
0.266
Gnomad SAS
AF:
0.406
Gnomad FIN
AF:
0.458
Gnomad MID
AF:
0.367
Gnomad NFE
AF:
0.456
Gnomad OTH
AF:
0.389
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.395
AC:
59905
AN:
151752
Hom.:
12242
Cov.:
31
AF XY:
0.392
AC XY:
29047
AN XY:
74180
show subpopulations
African (AFR)
AF:
0.306
AC:
12665
AN:
41374
American (AMR)
AF:
0.364
AC:
5544
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.380
AC:
1318
AN:
3464
East Asian (EAS)
AF:
0.266
AC:
1371
AN:
5154
South Asian (SAS)
AF:
0.405
AC:
1937
AN:
4788
European-Finnish (FIN)
AF:
0.458
AC:
4819
AN:
10516
Middle Eastern (MID)
AF:
0.371
AC:
109
AN:
294
European-Non Finnish (NFE)
AF:
0.456
AC:
30938
AN:
67906
Other (OTH)
AF:
0.387
AC:
814
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
1684
3368
5052
6736
8420
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
566
1132
1698
2264
2830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.415
Hom.:
1689
Bravo
AF:
0.385
Asia WGS
AF:
0.374
AC:
1302
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
4.1
DANN
Benign
0.79
PhyloP100
0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11564452; hg19: chr3-41274270; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.